Frequency of publication: Triannual
Language of publication: English; Starting year: 2016
Format of publication: Online
The NeuroPharmac Journal is an open access peer-reviewed journal committed to publishing high-quality articles in the field of Medical Research and Health Sciences.
‘NeuroPharmac Journal’ is an open-access official peer-reviewed Journal of ‘Author Gate Publications’ publishing three Issues per year (January-April; May-August; September-December).
The ‘NeuroPharmac Journal’ publishes articles from medical research and the health sciences area. The ‘NeuroPharmac Journal’ respects and follows the guidelines of the Committee on Publication Ethics (COPE) and Principles of Transparency and Best Practice for Scholarly Publications.
NeuroPharmac Journal is a member of CrossRef organization that makes research outputs easy to find, cite, link, assess, and reuse.
NeuroPharmac Journal is an open-access official peer-reviewed Journal Publishing Three Issues per year (Jauanry-April; May-August; September-December) and allowing open access to abstracts and full-text. The term ‘Neuro’ is devoted to the promotion of Medical and Healthcare related disciplines like Microbiology & Infectious diseases, Clinical research, Nursing research, Physiotherapy research, Occupational therapy research, Pharmaceutical research, Pharmacognosy & Phytochemistry, Pharmacology and Phytopharmacology, Pharmacy Practice, Clinical & Hospital Pharmacy with focus on various neurology updates on neurological disorders and their management.
While the term ‘Pharmac’ is related to research, review and current updates in Pharmaceutical Science field including Pharmaceutics, Pharmacology, Pharmaceutical, and Medicinal Chemistry, Pharmacognosy and Phytochemistry, Clinical and Hospital Pharmacy, Pharmaceutical Analysis, Complementary and alternative medicine, Environmental and behavioural science and computational biology and drug design.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.
